Compositions and methods for the prevention and treatment of cardiovascular diseases

1. A method for treating a subject having a calcium score of 46 and above or diagnosed with Buerger's Disease comprising administering by parenteral injection to the subject a stable composition comprising a therapeutically effective amount of an electro-activated solution, wherein

the electro-activated solution has an oxidation-reduction potential (ORP) in the range between −50 mV and −500 mV for a period of at least 12 months, a conductivity in the range between 11 and 15 mS/cm and a pH in the range between 6.5 and 7.6, and

the electro-activated solution comprises:

Magnesium sulfate hexahydrate

0.5-10%;

Sodium Bicarbonate

0.5-10%;

Ascorbic Acid

5.0-20%;

Niacinamide

0.2-2.0%;

Pyridocxin HCL

0.005-0.2%;

Calcium D Pantothenate

0.01-2.0%;

Thiamin HCl

0.1-1.0%;

Riboflavin

0.01-0.1%;

Cyanocobalamin

0.001-0.1%;

2-di-ethylaminoethanol

1.0-3.0%; and

Electro-Activated Water

5.0-500 ml.

2. The method of claim 1 , wherein the composition is administered intra-arterially or intravenously.

3. The method of claim 1 , wherein the subject is the subject having a calcium score of 46 and above.

4. The method of claim 2 , wherein the subject is the subject having a calcium score of 46 and above.

5. The method of claim 1 , wherein the subject is the subject diagnosed with Buerger's Disease.

6. The method of claim 2 , wherein the subject is the subject diagnosed with Buerger's Disease.